Abstract

Addressing unmet clinical needs: the potential of biosimilars in the treatment of rheumatic diseases.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Impact of Biological Agents and Tissue Engineering Approaches on the Treatment of Rheumatic Diseases
Marta Alves Da Silva ... Nuno M Neves
Tissue Engineering Part B: Reviews | VOL. 16
Marta Alves Da Silva, et. al.Marta Alves Da Silva ... Nuno M Neves
01 Jun 2010
Treatment of rheumatic disease with renal insufficiency
S. M. Weiner
Der Orthop�de | VOL. 48
S. M. WeinerS. M. Weiner
17 Sep 2019
Sulfasalazine-Related Hypersensitivity Reactions in Patients With Rheumatic Diseases.
Songul Cildag ... Taskin Senturk
JCR Journal of Clinical Rheumatology | VOL. 23
Songul Cildag, et. al.Songul Cildag ... Taskin Senturk
01 Mar 2017
Acupuncture in the treatment of rheumatic diseases.
Matxalen Amezaga Urruela ... Maria E Suarez-Almazor
Current Rheumatology Reports | VOL. 14
Matxalen Amezaga Urruela, et. al.Matxalen Amezaga Urruela ... Maria E Suarez-Almazor
07 Oct 2012
View more papers

More From: Rheumatology (Oxford, England)

Paper Title
Journal
Date
Author
Long-term outcomes of childhood-onset systemic lupus erythematosus.
A Mirguet ... B Bader-Meunier
Rheumatology (Oxford, England) | VOL. -
A Mirguet, et. al.A Mirguet ... B Bader-Meunier
15 Jul 2024
Avacopan for anti-neutrophil cytoplasm antibodies-associated vasculitis: a multicenter real-world study.
Charlotte Gabilan ... Stanislas Faguer
Rheumatology (Oxford, England) | VOL. -
Charlotte Gabilan, et. al.Charlotte Gabilan ... Stanislas Faguer
13 Jul 2024
A double-blind, placebo-controlled, randomized multiple dose phase 1b trial of a CDK4/6 inhibitor, TCK-276, in patients with active rheumatoid arthritis.
Daisuke Tasaki ... Hiroaki Sato
Rheumatology (Oxford, England) | VOL. -
Daisuke Tasaki, et. al.Daisuke Tasaki ... Hiroaki Sato
13 Jul 2024
Correction to: Five-year follow-up of patients with difficult-to-treat rheumatoid arthritis.
-
Rheumatology (Oxford, England) | VOL. -
--
13 Jul 2024
View more papers